Literature DB >> 19165924

Genome-wide association study identifies ANXA11 as a new susceptibility locus for sarcoidosis.

Sylvia Hofmann1, Andre Franke, Annegret Fischer, Gunnar Jacobs, Michael Nothnagel, Karoline I Gaede, Manfred Schürmann, Joachim Müller-Quernheim, Michael Krawczak, Philip Rosenstiel, Stefan Schreiber.   

Abstract

Sarcoidosis is a complex chronic inflammatory disorder with predominant manifestation in the lung. In the first genome-wide association study (> 440,000 SNPs) of this disease, comprising 499 German individuals with sarcoidosis and 490 controls, we detected a series of genetic associations. The strongest association signal maps to the ANXA11 (annexin A11) gene on chromosome 10q22.3. Validation in an independent sample (1,649 cases, 1,832 controls) confirmed the association (SNP rs2789679: P = 3.0 x 10(-13), rs7091565: P = 1.0 x 10(-5), allele-based test). Extensive fine mapping located the association signal to a region between exon 5 and exon 14 of ANXA11. A common nonsynonymous SNP (rs1049550, C > T, [corrected] R230C) was found to be strongly associated with sarcoidosis. The GWAS lead SNP and additional risk variants in the region (rs1953600, rs2573346, rs2784773) were in strong linkage disequilibrium with rs1049550. Annexin A11 has complex and essential functions in several biological pathways, including apoptosis and proliferation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19165924     DOI: 10.1038/ng.198

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  84 in total

1.  A genome-wide analysis of open chromatin in human tracheal epithelial cells reveals novel candidate regulatory elements for lung function.

Authors:  Jared M Bischof; Christopher J Ott; Shih-Hsing Leir; Nehal Gosalia; Lingyun Song; Darin London; Terrence S Furey; Calvin U Cotton; Gregory E Crawford; Ann Harris
Journal:  Thorax       Date:  2011-12-14       Impact factor: 9.139

2.  TNFA, ANXA11 and BTNL2 Polymorphisms in CVID Patients with Granulomatous Disease.

Authors:  David Boutboul; Nicolas Vince; Matthieu Mahevas; Jean-Christophe Bories; Claire Fieschi
Journal:  J Clin Immunol       Date:  2016-01-18       Impact factor: 8.317

Review 3.  A concise review of pulmonary sarcoidosis.

Authors:  Robert P Baughman; Daniel A Culver; Marc A Judson
Journal:  Am J Respir Crit Care Med       Date:  2010-10-29       Impact factor: 21.405

Review 4.  Sarcoidosis--scientific progress and clinical challenges.

Authors:  Edward S Chen; David R Moller
Journal:  Nat Rev Rheumatol       Date:  2011-07-12       Impact factor: 20.543

5.  Co-occurrence of rheumatoid arthritis and sarcoidosis.

Authors:  Şenol Kobak; Ahmet Adnan Karaarslan; Hatice Yilmaz; Fidan Sever
Journal:  BMJ Case Rep       Date:  2015-07-06

6.  Familial sarcoidosis: Report of a mother and her son.

Authors:  Ekin Akyıldız; Şenol Kobak
Journal:  Eur J Rheumatol       Date:  2017-10-25

Review 7.  The state of genome-wide association studies in pulmonary disease: a new perspective.

Authors:  Jamie L Todd; David B Goldstein; Dongliang Ge; Jason Christie; Scott M Palmer
Journal:  Am J Respir Crit Care Med       Date:  2011-07-28       Impact factor: 21.405

8.  A functional haplotype in the 3'untranslated region of TNFRSF1B is associated with tuberculosis in two African populations.

Authors:  Marlo Möller; Friederike Flachsbart; Andreas Till; Thorsten Thye; Rolf D Horstmann; Christian G Meyer; Ivy Osei; Paul D van Helden; Eileen G Hoal; Stefan Schreiber; Almut Nebel; Andre Franke
Journal:  Am J Respir Crit Care Med       Date:  2009-12-10       Impact factor: 21.405

9.  [Genetic risk profile of sarcoidosis].

Authors:  A Fischer; G Zissel; A Nebel; J Müller-Quernheim
Journal:  Internist (Berl)       Date:  2014-02       Impact factor: 0.743

10.  Lack of association between toll-like receptor 4 gene polymorphisms and sarcoidosis-related uveitis in Japan.

Authors:  Yuri Asukata; Masao Ota; Akira Meguro; Yoshihiko Katsuyama; Mami Ishihara; Kenichi Namba; Nobuyoshi Kitaichi; Shin-Ichiro Morimoto; Toshikatsu Kaburaki; Yasutaka Ando; Shinobu Takenaka; Hidetoshi Inoko; Shigeaki Ohno; Nobuhisa Mizuki
Journal:  Mol Vis       Date:  2009-12-10       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.